AKT1 and acute promyelocytic leukemia: Expressions of p-IRS-1 and p-AKT were significantly inhibited by palmitate treatment and those effects were dose- dependently attenuated by APL treatment under insulin-stimulated conditions (Fig 1C and 1D).